Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 9;118(31-32):538-539.
doi: 10.3238/arztebl.m2021.0182.

Trends Over Time in Breast-Cancer-Specific Mortality in Germany

Annika Waldmann, Joachim Hübner, Alexander Katalinic

Trends Over Time in Breast-Cancer-Specific Mortality in Germany

Annika Waldmann et al. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Trends over time in age group-specific breast cancer mortality in Germany (y-axis: log scale) – annual rates and case numbers for the prescreening time period (2003/2004) and the current period (2017/2018), absolute and relative changes in rates between 2003/2004 and 2017/2018 as well as results of the trend analyses. The dotted line marks the nationwide implementation of mammography screening in Germany in 2005. Values in square brackets are 95% confidence intervals; APC, annual percentage change.
See this image and copyright information in PMC

References

    1. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Brussels, Belgium: European Communities. 2006 - PubMed
    1. Mandrik O, Zielonke N, Meheus F, et al. Systematic reviews as a ‚lens of evidence‘: Determinants of benefits and harms of breast cancer screening. Int J Cancer. 2019;145:994–1006. - PMC - PubMed
    1. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2020;147:709–718. - PubMed
    1. Duffy SW, Vulkan D, Cuckle H, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol. 2020;21:1165–1172. - PMC - PubMed
    1. Lynge E, Beau AB, von Euler-Chelpin M, et al. Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark. Breast Cancer Res Treat. 2020;184:891–899. - PMC - PubMed